GPX4 and chronic obstructive pulmonary disease: The expression of GPx4 was significantly increased in healthy myotubes after EPS (p = 0.046; Figure 6J), and variations in GPx4 expression were significantly different (p = 0.020; Figure 6K) between healthy myotubes (+53.5%) and COPD myotubes (+7.8%).